BIOVENTUS INC. - CLASS A COMMON STOCK

Bioventus to Report First Quarter of Fiscal Year 2023 Financial Results on May 11, 2023

03 May 2023 08:30:00 By Nasdaq GlobeNewswire

Bioventus Announces CEO Leadership Change

05 Apr 2023 08:00:00 By Nasdaq GlobeNewswire

Bioventus Reports Fourth Quarter and Full-Year 2022 Financial Results

31 Mar 2023 07:30:01 By Nasdaq GlobeNewswire

Bioventus Enters into an Amendment with its Credit Agreement Lenders to Enhance Financial and Operational Flexibility

31 Mar 2023 07:00:00 By Nasdaq GlobeNewswire

Bioventus Reschedules Reporting of Fourth Quarter Fiscal Year 2022 Financial Results to March 31, 2023

29 Mar 2023 08:55:09 By Nasdaq GlobeNewswire

Bioventus to Report Fourth Quarter of Fiscal Year 2022 Financial Results on March 30, 2023

16 Mar 2023 08:30:00 By Nasdaq GlobeNewswire

Bioventus Enters into Settlement Agreement to Preserve Maximum Optionality – Up To $350mm of Potential Liability Reduction and a Release of Future Claims related to the CartiHeal Acquisition

28 Feb 2023 07:30:00 By Nasdaq GlobeNewswire

Bioventus to Present at the 41st Annual J.P. Morgan Healthcare Conference

04 Jan 2023 07:00:00 By Nasdaq GlobeNewswire

Bioventus Issues Revised Third Quarter Results; Updates Full-Year 2022 Financial Guidance

21 Nov 2022 17:15:01 By Nasdaq GlobeNewswire

Bioventus Files for Extension to File Form 10-Q for the Period Ended October 1, 2022

16 Nov 2022 17:15:00 By Nasdaq GlobeNewswire

Bioventus Reports Third Quarter Results; Updates Full-Year 2022 Financial Guidance

08 Nov 2022 07:30:01 By Nasdaq GlobeNewswire

Bioventus to Report Third Quarter of Fiscal Year 2022 Financial Results on November 8, 2022

31 Oct 2022 07:00:00 By Nasdaq GlobeNewswire

Bioventus to Showcase Full Orthobiologics and Ultrasonic Portfolio at NASS in Chicago   

12 Oct 2022 08:00:01 By Nasdaq GlobeNewswire

Bioventus to Present at the Morgan Stanley Global Healthcare Conference

30 Aug 2022 08:00:01 By Nasdaq GlobeNewswire

Bioventus Reports Second Quarter Results; Updates Full-Year 2022 Financial Guidance

11 Aug 2022 07:00:03 By Nasdaq GlobeNewswire

Bioventus Receives FDA 510(k) Clearance for SonaStar Elite  

03 Aug 2022 07:00:02 By Nasdaq GlobeNewswire

Bioventus to Report Second Quarter of Fiscal Year 2022 Financial Results on August 11, 2022

26 Jul 2022 07:00:00 By Nasdaq GlobeNewswire

Bioventus Completes CartiHeal Acquisition

12 Jul 2022 08:30:00 By Nasdaq GlobeNewswire

Bioventus Amends CartiHeal Acquisition Structure

21 Jun 2022 07:30:00 By Nasdaq GlobeNewswire

Bioventus Reports First Quarter Results; Reaffirms Full-Year 2022 Financial Guidance

10 May 2022 07:00:04 By Nasdaq GlobeNewswire